Since the start of the year, Euroapi, manufacturer of active pharmaceutical ingredients, has lost more than half of its value. A stock market journey which is transforming into a path of the cross for the shareholders of the group of the Sanofi subsidiary. Explanations from Laurent Grassin, editorial director of Boursorama. Ecorama of March 19, 2024, presented by David Jacquot on Boursorama.com